Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04262856
Title Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer (ARC-7)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Arcus Biosciences, Inc.
Indications

lung non-squamous non-small cell carcinoma

lung squamous cell carcinoma

Therapies

AB154 + AB928 + Zimberelimab

Zimberelimab

AB154 + Zimberelimab

Age Groups: senior | adult
Covered Countries USA | CAN

Additional content available in CKB BOOST